Physician profile
Ricky Hendrix
NPI 1124021381
$819.92
in general payments reported to CMS, 2019-2025
6 companies · $18.79 in 2025
The $18.79 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $169 · 2021: $219 · 2022: $214 · 2023: $69.79 · 2025: $18.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $88.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $88.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akebia Therapeutics INC | $392.13 | 2020-2023 | Auryxia |
| Fresenius USA Marketing, INC. | $280.18 | 2019-2025 | Velphoro |
| Amgen INC. | $65.07 | 2019-2022 | |
| Horizon Therapeutics Plc | $43.82 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $21.21 | 2019 | |
| Vifor Pharma, INC. | $17.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricky Hendrix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.